Lipoprotein(a) and Cardiovascular Diseases

JAMA. 2021 Jul 27;326(4):352-353. doi: 10.1001/jama.2021.3632.

Authors

Hannah Miksenas¹, James L Januzzi Jr^{1

2}, Pradeep Natarajan^{1

2

3}

Affiliations

¹ Division of Cardiology, Massachusetts General Hospital, Boston.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts.
³ Program in Medical and Population Genetics, Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

PMID: 34236417
DOI: 10.1001/jama.2021.3632

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cardiovascular Diseases / etiology*
Humans
Hypolipidemic Agents / therapeutic use
Lipoprotein(a) / blood*
Risk Factors

Substances

Hypolipidemic Agents
Lipoprotein(a)

Grants and funding